Crossmark

Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on 18F-FDG PET/CT

Crossref DOI link: https://doi.org/10.1007/s00261-024-04226-7

Published Online: 2024-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yun

Hu, Yuxiao https://orcid.org/0000-0003-3520-6634
Zhao, Shuang

Xu, Shanshan
Funding

Funding for this research was provided by:

The Young Talents Program of Jiangsu Cancer Hospital (YC201801)

The Special Project of Clinical Research on Truth-seeking (ZL202210)

Key Project of Jiangsu Commission of Health (K2023021)
License Information

Text and Data Mining valid from 2024-03-25

Version of Record valid from 2024-03-25
More Information

Article History

Received: 10 November 2023

Revised: 26 January 2024

Accepted: 29 January 2024

First Online: 25 March 2024

Declarations

:

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current

Any future updates will be listed below